These experiments demonstrate that these anionophores have a limited toxicity, and could be used to promote anion transport in cells, i.e., are good candidates to replace the defective or missing CFTR in an attempt to design a new, mutant independent cystic fibrosis therapeutic approach. Here, CFTR is linked to cystic fibrosis.